Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.

Barøy T, Kresse SH, Skårn M, Stabell M, Castro R, Lauvrak S, Llombart-Bosch A, Myklebost O, Meza-Zepeda LA.

Mol Cancer. 2014 Apr 28;13:93. doi: 10.1186/1476-4598-13-93.

2.

Generation and characterization of an immortalized human mesenchymal stromal cell line.

Skårn M, Noordhuis P, Wang MY, Veuger M, Kresse SH, Egeland EV, Micci F, Namløs HM, Håkelien AM, Olafsrud SM, Lorenz S, Haraldsen G, Kvalheim G, Meza-Zepeda LA, Myklebost O.

Stem Cells Dev. 2014 Oct 1;23(19):2377-89. doi: 10.1089/scd.2013.0599. Epub 2014 Jun 30.

PMID:
24857590
3.

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.

Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, Myklebost O.

Br J Cancer. 2013 Oct 15;109(8):2228-36. doi: 10.1038/bjc.2013.549. Epub 2013 Sep 24.

4.

Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.

Ohnstad HO, Castro R, Sun J, Heintz KM, Vassilev LT, Bjerkehagen B, Kresse SH, Meza-Zepeda LA, Myklebost O.

Cancer. 2013 Mar 1;119(5):1013-22. doi: 10.1002/cncr.27837. Epub 2012 Nov 16.

5.

Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.

Kresse SH, Rydbeck H, Skårn M, Namløs HM, Barragan-Polania AH, Cleton-Jansen AM, Serra M, Liestøl K, Hogendoorn PC, Hovig E, Myklebost O, Meza-Zepeda LA.

PLoS One. 2012;7(11):e48262. doi: 10.1371/journal.pone.0048262. Epub 2012 Nov 7.

6.

Modulation of the osteosarcoma expression phenotype by microRNAs.

Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM, Myklebost O.

PLoS One. 2012;7(10):e48086. doi: 10.1371/journal.pone.0048086. Epub 2012 Oct 25.

7.

Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.

Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O.

Sarcoma. 2012;2012:639038. doi: 10.1155/2012/639038. Epub 2012 Feb 28.

8.

Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.

Kuijjer ML, Rydbeck H, Kresse SH, Buddingh EP, Lid AB, Roelofs H, Bürger H, Myklebost O, Hogendoorn PC, Meza-Zepeda LA, Cleton-Jansen AM.

Genes Chromosomes Cancer. 2012 Jul;51(7):696-706. doi: 10.1002/gcc.21956. Epub 2012 Mar 27.

PMID:
22454324
9.

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts.

Kuijjer ML, Namløs HM, Hauben EI, Machado I, Kresse SH, Serra M, Llombart-Bosch A, Hogendoorn PC, Meza-Zepeda LA, Myklebost O, Cleton-Jansen AM.

BMC Med Genomics. 2011 Sep 20;4:66. doi: 10.1186/1755-8794-4-66.

10.

Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations.

Kresse SH, Meza-Zepeda LA, Machado I, Llombart-Bosch A, Myklebost O.

Cancer. 2012 Jan 15;118(2):558-70. doi: 10.1002/cncr.26276. Epub 2011 Jun 28.

11.

DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

Kresse SH, Ohnstad HO, Bjerkehagen B, Myklebost O, Meza-Zepeda LA.

PLoS One. 2010 Nov 9;5(11):e15378. doi: 10.1371/journal.pone.0015378.

12.

Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours.

Kresse SH, Szuhai K, Barragan-Polania AH, Rydbeck H, Cleton-Jansen AM, Myklebost O, Meza-Zepeda LA.

BMC Res Notes. 2010 Aug 8;3:223. doi: 10.1186/1756-0500-3-223.

13.

Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.

Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J.

Blood. 2010 Sep 2;116(9):1489-97. doi: 10.1182/blood-2010-03-272278. Epub 2010 May 26.

14.

A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models.

Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, Navarro S, Llombart-Bosch A.

Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):453-61. doi: 10.1097/PAI.0b013e3181daace3.

PMID:
20436344
15.

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.

Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C.

Genes Chromosomes Cancer. 2010 Jan;49(1):40-51. doi: 10.1002/gcc.20717.

PMID:
19787792
16.

LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.

Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA.

Genes Chromosomes Cancer. 2009 Aug;48(8):679-93. doi: 10.1002/gcc.20675.

PMID:
19441093
17.

OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.

Våtsveen TK, Tian E, Kresse SH, Meza-Zepeda LA, Gabrea A, Glebov O, Dai HY, Sundan A, Kuehl WM, Børset M.

Leuk Res. 2009 Dec;33(12):1670-7. doi: 10.1016/j.leukres.2009.03.001. Epub 2009 Apr 23.

PMID:
19395026
18.

Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.

Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN, Ibrahim SO.

Oncol Rep. 2008 Oct;20(4):825-43.

PMID:
18813824
19.

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.

Kresse SH, Skårn M, Ohnstad HO, Namløs HM, Bjerkehagen B, Myklebost O, Meza-Zepeda LA.

Mol Cancer. 2008 Jun 3;7:48. doi: 10.1186/1476-4598-7-48.

20.

Array-CGH fine mapping of minor and cryptic HR-CGH detected genomic imbalances in 80 out of 590 patients with abnormal development.

Lybaek H, Meza-Zepeda LA, Kresse SH, Høysaeter T, Steen VM, Houge G.

Eur J Hum Genet. 2008 Nov;16(11):1318-28. doi: 10.1038/ejhg.2008.78. Epub 2008 May 7. Erratum in: Eur J Hum Genet. 2009 Mar;17(3):402.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk